Enrollments for Phase 2B StudyIn the news release today the company stated the following:
Phase 2b Study Completion and Data Readout
The Company will provide an update to the market on a projected completion date of the study as well as when the read out of the data can be expected when enrollment in the study reaches the 50% target level.
The phase 2B study accounts for 150 patients and today they announced patient count at 50. I believe based on comments above they will be providing a update once they have 75 patients enrolled which should happen pretty quickly in my opinion.
They also stated they expected to see enrollments pick up each week which suggests they may enroll the 150 faster than what they initially thought.